Literature DB >> 28904036

Sacubitril-valsartan: novel therapy for heart failure.

Evan Sehn1, Terrence McDonald2, Adrienne J Lindblad3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28904036      PMCID： PMC5597015     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  7 in total

Review 1.  Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review.

Authors:  Jaime Latour-Pérez; Francisco Javier Coves-Orts; Carmen Abad-Terrado; Víctor Abraira; Javier Zamora
Journal:  Eur J Heart Fail       Date:  2005-11-21       Impact factor: 15.534

2.  The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.

Authors:  Gordon W Moe; Justin A Ezekowitz; Eileen O'Meara; Serge Lepage; Jonathan G Howlett; Steve Fremes; Abdul Al-Hesayen; George A Heckman; Howard Abrams; Anique Ducharme; Estrellita Estrella-Holder; Adam Grzeslo; Karen Harkness; Sheri L Koshman; Michael McDonald; Robert McKelvie; Miroslaw Rajda; Vivek Rao; Elizabeth Swiggum; Sean Virani; Shelley Zieroth; J Malcolm O Arnold; Tom Ashton; Michel D'Astous; Michael Chan; Sabe De; Paul Dorian; Nadia Giannetti; Haissam Haddad; Debra L Isaac; Simon Kouz; Marie-Hélène Leblanc; Peter Liu; Heather J Ross; Bruce Sussex; Michel White
Journal:  Can J Cardiol       Date:  2014-12-19       Impact factor: 5.223

3.  Aldosterone antagonists in systolic heart failure.

Authors:  Adrienne J Lindblad; G Michael Allan
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

Review 4.  The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice.

Authors:  Jonathan G Howlett; Michael Chan; Justin A Ezekowitz; Karen Harkness; George A Heckman; Simon Kouz; Marie-Hélène Leblanc; Gordon W Moe; Eileen O'Meara; Howard Abrams; Anique Ducharme; Adam Grzeslo; Peter G Hamilton; Sheri L Koshman; Serge Lepage; Michael McDonald; Robert McKelvie; Miroslaw Rajda; Elizabeth Swiggum; Sean Virani; Shelley Zieroth
Journal:  Can J Cardiol       Date:  2015-06-25       Impact factor: 5.223

5.  Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive Hypertension.

Authors:  Tzung-Dau Wang; Ru-San Tan; Hae-Young Lee; Sang-Hyun Ihm; Moo-Yong Rhee; Brian Tomlinson; Parasar Pal; Fan Yang; Elizabeth Hirschhorn; Margaret F Prescott; Markus Hinder; Thomas H Langenickel
Journal:  Hypertension       Date:  2016-11-14       Impact factor: 10.190

6.  Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors:  John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

7.  Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.

Authors:  Orly Vardeny; Brian Claggett; Milton Packer; Michael R Zile; Jean Rouleau; Karl Swedberg; John R Teerlink; Akshay S Desai; Martin Lefkowitz; Victor Shi; John J V McMurray; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2016-06-10       Impact factor: 15.534
  7 in total
  1 in total

1.  Quick and painless: 2018 Updates on guideline recommendations.

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2019-11       Impact factor: 3.275
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.